About MAG

A boutique agency built for senior access

Medical Advisers Group was founded in 2015 with a clear premise: pharma teams need medical communications partners who combine deep scientific expertise with the speed and flexibility of a boutique operation. 50+ pharma teams across EMEA, Asia, and the Middle East.
10+
Years in medical
communications
50+
Pharma clients
served globally
30+
Markets across
EMEA & Asia
We built MAG around one principle: every pharma team deserves a medical communications partner who treats their brand as their own. No layers, no junior handoffs — just senior experts who know your science and your markets.
Yakov Pakhomov, MD PhD
Medical Director, MAG
Why MAG

What makes us different

Boutique means senior access

No account managers. No junior layers. You work directly with the experts who write, review, and deliver your materials.

EMEA-fluent, locally adapted

We don’t just translate. We adapt evidence narratives for local payers, regulators, and HCPs — across 30+ markets.

Own AI infrastructure

We built proprietary AI tools — Evidence Scanner™ — that accelerate literature search, monitoring, fact-checking, and AI-enhanced EDC.

Real work. Measurable outcomes.

Selected case studies

View all →
OncologyEvidence Dossier
Ribociclib post-ASCO update: field-ready summary for 12 EMEA markets in 48 hours
✓ MSL teams received updated materials within 48h of congress close
GynaecologyAdvisory Board
Expert consensus on postmenopausal hormonal therapy: Delphi-based, 65 authors, 5 scientific societies endorsed
✓ Published in high-impact journal, integrated into 2 national guidelines
Rare DiseasePatient Journey
Patient journey analysis: identifying undiagnosed patients for orphan drug across fragmented diagnostic landscape
✓ Patient-finding algorithm deployed; undiagnosed patients identified
Member of
France Biotech

AI infrastructure is
our priority

We invested in building our own AI infrastructure from the ground up. Our proprietary platform Evidence Scanner™ powers literature search, monitoring, fact-checking, and AI-enhanced EDC.

As a member of France Biotech, we are committed to advancing health technology innovation and scientific integrity in everything we build.

Evidence Scanner™ Literature Monitoring Fact-Checking AI-Enhanced EDC AI-Accelerated Delivery
The core idea of our work

What we
solve

We help regional and affiliate teams turn complex evidence into local-market action — with speed, localization, and alignment across Medical, Marketing, and Market Access.

See all challenges
01
Affiliate localization: got a 200-slide HQ deck, needs a 12-slide country brief by Thursday.
02
Comparator mismatch: local HTA uses a different comparator. The global argument doesn’t hold.
03
Congress debrief: ASCO just closed. What changed? What do we update? What do we tell the field?
04
Expert consensus: we need a Delphi advisory — but a classic process takes 6 months.
05
Payer evidence gap: RWE collected in-market but never turned into a usable HTA dossier.
 + 6 more challenges — see the full list →
Get in touch
Let’s discuss
your project
Whether you need a value dossier adapted for 5 markets, an advisory board designed from scratch, a slide deck or content package delivered fast and to the highest standard, or an AI-powered literature monitoring solution — we’re ready to help.
✉
📞
🌐
🇫🇷
Bordeaux, France
Nouvelle-Aquitaine
Medical Advisers Group
Follow us on LinkedIn →
Send us a message
We’ll respond within one business day.
Or book a 20-min call →